News
An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to prevent delayed cerebral ischemia in patients with subarachnoid hemorrhage. The ...
--Grace Therapeutics, Inc., a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant ...
GTx-104 provides a convenient IV delivery of nimodipine in the Intensive Care Unit potentially eliminating the need for nasogastric tube administration in unconscious or dysphagic patients.
Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.. If you have the appropriate software installed, you can ...
The study highlights the mechanism of action of petosemtamab, which is designed to combat cancer by blocking EGFR ligands, promoting internalization and degradation of EGFR in LGR5+ cells, and ...
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been ...
With this approval, we'll have a unique mechanism of action. We'll have another treatment option [with] reduced resistance due to its mechanism of action, and I think that's really going to drive ...
Previously known as JNJ-2113, icotrokinra (Protagonist Therapeutics, Johnson & Johnson) has a very specific mechanism of action for the treatment of moderate to severe plaque psoriasis, according ...
Joshua K. Sabari, MD, describes the mechanism of action of lurbinectedin as a synthetic alkaloid that binds to guanine residues in the minor groove of DNA, forming adducts that disrupt DNA repair ...
An approachable framework for the scalable implementation of proteome-wide thermal shift assays to assess drug mechanisms of action.
Keywords: cystic fibrosis, ivacaftor, nisoldipine, nimodipine, drug-drug interaction, pharmacokinetics Citation: Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, Xu R-a and Wu W (2024) Corrigendum: ...
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF NYMALIZE® (NIMODIPINE) ORAL SOLUTION 30 MG/5 ML PREFILLED ENFIT® SYRINGE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results